JUN 13, 2014 12:00 AM PDT

Penn Researchers Show How Human Learning Is Altered by Electrical Stimulation of Dopamine Neurons

Stimulation of a certain population of neurons within the brain can alter the learning process, according to a team of neuroscientists and neurosurgeons at the University of Pennsylvania. A report in the Journal of Neuroscience describes for the first time that human learning can be modified by stimulation of dopamine-containing neurons in a deep brain structure known as the substantia nigra. Researchers suggest that the stimulation may have altered learning by biasing individuals to repeat physical actions that resulted in reward.

"Stimulating the substantia nigra as participants received a reward led them to repeat the action that preceded the reward, suggesting that this brain region plays an important role in modulating action-based associative learning," said co-senior author Michael Kahana, PhD, professor of psychology in Penn's School of Arts and Sciences.

Eleven study participants underwent deep brain stimulation (DBS) treatment for Parkinson's disease. During an awakened portion of the procedure, participants played a computer game where they chose between pairs of objects that carried different reward rates (like choosing between rigged slot machines in a casino). The objects were displayed on a computer screen, and participants made selections by pressing buttons on hand-held controllers. When they got a reward, they were shown a green screen and heard a sound of a cash register (as they might in a casino). Participants were not told which objects were more likely to yield reward, but that their task was to figure out which ones were "good" options based on trial and error.

When stimulation was provided in the substantia nigra following reward, participants tended to repeat the button press that resulted in a reward. This was the case even when the rewarded object was no longer associated with that button press, resulting in poorer performance on the game when stimulation was given (48 percent accuracy), compared to when stimulation was not given (67 percent).

"While we've suspected, based on previous studies in animal models, that these dopaminergic neurons in the substainia nigra play an important role in reward learning, this is the first study to demonstrate in humans that electrical stimulation near these neurons can modify the learning process," said the study's co-senior author Gordon Baltuch, MD, PhD, professor of neurosurgery in the Perelman School of Medicine at the University of Pennsylvania. "This result also has possible clinical implications through modulating pathological reward-based learning, for conditions such as substance abuse or problem gambling, or enhancing the rehabilitation process in patients with neurological deficits."

The research team included lead study author Ashwin Ramayya, a neuroscience MD/PhD student at Penn, along with Amrit Misra from Drexel University. The study was supported by the National Institutes of Health (MH55687).
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Miracle Drug for Rare Genetic Disease Causes Price Concerns
A newly approved “miracle drug” called Zolgensma will be used to treat children with spinal muscular atrophy, or SMA. Unfortunately, the therap...
SEP 20, 2019
Cell & Molecular Biology
SEP 20, 2019
E-cigarettes can Damage Neural Stem Cells
Some stem cells are with us throughout life. They help replenish cells that we need, but they are also very sensitive to stresses like toxins....
SEP 20, 2019
Genetics & Genomics
SEP 20, 2019
Is Autism Really 81% Genetic?
A condition that affects 1 in 37 boys and 1 in 151 girls in the US, research is fast-showing that genetics account for 81% of the risk factor for someone t...
SEP 20, 2019
Neuroscience
SEP 20, 2019
Elon Musk showcases advances in elusive Neuralink brain implant
Last week, Elon Musk took the stage in front of an invitation-only crowd at the CaliforniaAcademy of Sciences to unveil his latest foray into connecting br...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Does Microdosing Really Boost Productivity and Creativity?
Microdosing is the practice of ingesting very low doses of psychedelic substances, typically a twentieth of a recreational dose. In particular, Lysergic ac...
SEP 20, 2019
Neuroscience
SEP 20, 2019
Scientists discover new pain-sensing organ in skin
Schwann cells are octopus-like cells in the nervous system that wrap around nerve cells, jelly-roll fashion, to form a special insulating layer. These cell...
Loading Comments...